A Study of Belantamab Mafodotin in Patients With Relapsed or Refractory AL Amyloidosis

NCT04617925 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

NETWORK

Sponsor class

Conditions

AL Amyloidosis

Interventions

DRUG: Belantamab mafodotin

Sponsor

Stichting European Myeloma Network

Collaborators

[object Object]